Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-19

FDA Approved: QUETIAPINE — Supplemental Application (Solco Healthcare U.S., LLC)

View source ↗

Summary

FDA approved a supplemental application for quetiapine from Solco Healthcare U.S., LLC to authorize a generic version of the drug for the U.S. market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quetiapine (quetiapine)

Snippet

SUPPL AP for QUETIAPINE (QUETIAPINE)